Inhibition of thymidine kinase by P1-(adenosine-5')-P5-(thymidine-5')-pentaphosphate.
Potential bisubstrate analogs, with adenosine and thymidine joined at their 5' positions by polyphosphoryl linkages of varying lengths (ApndT, where n = the number of phosphoryl groups), were examined as inhibitors of cytosolic thymidine kinase from blast cells of patients with acute myelocytic leukemia. Ki values were 1.2 microM for Ap3dT, 0.31 microM for Ap4dT, 0.12 microM for Ap5dT, and 0.19 microM for Ap6dT. The best inhibitor of the cytosolic enzyme, Ap5dT, was somewhat less effective as an inhibitor of the mitochondrial enzyme (Ki = 0.50 microM). In addition to their inhibitory modes of binding by the cytosolic enzyme, these compounds were bound at considerably lower concentrations (Kd = 0.029 microM for Ap4dT, 0.0025 microM for Ap5dT, and 0.0027 microM for Ap4dT), in such a way as to protect the cytosolic enzyme from thermal inactivation at 37 degrees C in the absence of substrates.
Bone
R
R
Cheng
Y C
YC
Wolfenden
R
R
D000227:Adenine Nucleotides / Q000138:chemical synthesis / Q000494:pharmacology*; D003600:Cytosol / Q000201:enzymology; D015226:Dinucleoside Phosphates; D006801:Humans; D007202:Indicators and Reagents; D007700:Kinetics; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology*; D009682:Magnetic Resonance Spectroscopy; D013329:Structure-Activity Relationship; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors*; D013942:Thymine Nucleotides / Q000138:chemical synthesis / Q000494:pharmacology*
D000227:Adenine Nucleotides; D015226:Dinucleoside Phosphates; D007202:Indicators and Reagents; D013942:Thymine Nucleotides; C048631:P(1)-(adenosine-5')-P(5)-(thymidine-5')-pentaphosphate; D013937:Thymidine Kinase